930 related articles for article (PubMed ID: 12877806)
21. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
22. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus.
Cavalcante P; Serafini B; Rosicarelli B; Maggi L; Barberis M; Antozzi C; Berrih-Aknin S; Bernasconi P; Aloisi F; Mantegazza R
Ann Neurol; 2010 Jun; 67(6):726-38. PubMed ID: 20517934
[TBL] [Abstract][Full Text] [Related]
24. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
[TBL] [Abstract][Full Text] [Related]
25. Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells.
Deshpande CG; Badve S; Kidwai N; Longnecker R
Lab Invest; 2002 Sep; 82(9):1193-9. PubMed ID: 12218080
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
27. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.
Taylor GS; Haigh TA; Gudgeon NH; Phelps RJ; Lee SP; Steven NM; Rickinson AB
J Virol; 2004 Jan; 78(2):768-78. PubMed ID: 14694109
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
29. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract.
Kobashi Y; Nakamura S; Sasajima Y; Koshikawa T; Yatabe Y; Kitoh K; Mori S; Ueda R; Yamabe H; Suchi T
Histopathology; 1996 Feb; 28(2):111-20. PubMed ID: 8834518
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1.
Yamamoto T; Nakamura Y; Kishimoto K; Takeuchi H; Shirakata M; Mitsuya T; Hirai K
Virus Res; 1999 Dec; 65(1):43-55. PubMed ID: 10564752
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
32. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
33. Tissue markers of Epstein-Bar virus (EBV) infection in B-cell non-Hodgkin's lymphomas.
Kasprzak A; Spachacz R; Hałoń A; Jeleń M; Stefańska K; Wachowiak J; Trejster E; Zabel M
Med Wieku Rozwoj; 2006; 10(3 Pt 1):639-48. PubMed ID: 17317895
[TBL] [Abstract][Full Text] [Related]
34. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
He JH; Zong YS; Zhang M; Zhong BL; Liang YJ; Liang XM
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
[TBL] [Abstract][Full Text] [Related]
35. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
[TBL] [Abstract][Full Text] [Related]
38. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
[TBL] [Abstract][Full Text] [Related]
39. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
[TBL] [Abstract][Full Text] [Related]
40. [The immunophenotypic features of primary nasal non-Hodgkin's lymphomas and its association with Epstin-Barr virus].
Ming M; Wang D; Ming X; Li G; Yi J; Yao J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):342-4. PubMed ID: 16075983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]